PMID- 30033478
OWN - NLM
STAT- MEDLINE
DCOM- 20200505
LR  - 20200505
IS  - 1573-7322 (Electronic)
IS  - 1382-4147 (Linking)
VI  - 24
IP  - 1
DP  - 2019 Jan
TI  - Diagnostic and prognostic role of cardiac magnetic resonance in acute 
      myocarditis.
PG  - 81-90
LID - 10.1007/s10741-018-9724-x [doi]
AB  - Acute myocarditis (AM) is commonly found in everyday clinical practice. 
      Differential diagnosis between various causes of myocardial damage with 
      non-obstructive coronary arteries can be cumbersome for clinician. Moreover, AM 
      may be provoked by a number of different causes and clinical presentation can be 
      heterogeneous with potential overlap going from asymptomatic or subclinical to 
      severe heart failure, arrhythmias, and death. Cardiac magnetic resonance (CMR) 
      over the last decades has proven to be the diagnostic technique of choice since 
      it allows identifying AM with excellent diagnostic accuracy. Latest technological 
      advancement with parametric imaging such as T1 and T2 mapping further increases 
      sensitivity and provides additional help towards a correct diagnosis. CMR however 
      is no longer to be considered as a mere diagnostic tool but also as a powerful 
      source of prognostic information. Scientific evidence has corroborated CMR's role 
      beyond diagnosis demonstrating how late gadolinium enhancement (LGE) presence is 
      a powerful predictor of cardiac events and how the presence of septal LGE is to 
      be considered of worst prognosis regardless of LGE extension even in patients 
      with preserved global systolic function. CMR should be routinely performed in all 
      patients with AM suspicion since its diagnostic and prognostic role is of 
      paramount important and could modify therapeutic strategy and subsequent clinical 
      decisions.
FAU - Grigoratos, Chrysanthos
AU  - Grigoratos C
AD  - Fondazione Gabriele Monasterio CNR/Regione Toscana, via Giuseppe Moruzzi, 1, 
      56124, Pisa, Italy. cgrigoratos@ftgm.it.
AD  - Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy. 
      cgrigoratos@ftgm.it.
FAU - Di Bella, Gianluca
AU  - Di Bella G
AD  - Clinical and Experimental Department of Medicine and Pharmacology, University of 
      Messina, Messina, Italy.
FAU - Aquaro, Giovanni Donato
AU  - Aquaro GD
AD  - Fondazione Gabriele Monasterio CNR/Regione Toscana, via Giuseppe Moruzzi, 1, 
      56124, Pisa, Italy.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Heart Fail Rev
JT  - Heart failure reviews
JID - 9612481
RN  - 0 (Contrast Media)
RN  - AU0V1LM3JT (Gadolinium)
SB  - IM
MH  - Acute Disease
MH  - Clinical Decision-Making/methods
MH  - Contrast Media/metabolism
MH  - Data Accuracy
MH  - Diagnosis, Differential
MH  - Female
MH  - Gadolinium/metabolism
MH  - Humans
MH  - Magnetic Resonance Imaging, Cine/*methods
MH  - Male
MH  - Myocarditis/*diagnostic imaging
MH  - Prognosis
MH  - Septum of Brain/metabolism
OTO - NOTNLM
OT  - Cardiac magnetic resonance
OT  - Late gadolinium enhancement
OT  - Myocardial fibrosis
OT  - Myocardial oedema
OT  - Myocarditis
OT  - Prognosis
EDAT- 2018/07/24 06:00
MHDA- 2020/05/06 06:00
CRDT- 2018/07/24 06:00
PHST- 2018/07/24 06:00 [pubmed]
PHST- 2020/05/06 06:00 [medline]
PHST- 2018/07/24 06:00 [entrez]
AID - 10.1007/s10741-018-9724-x [pii]
AID - 10.1007/s10741-018-9724-x [doi]
PST - ppublish
SO  - Heart Fail Rev. 2019 Jan;24(1):81-90. doi: 10.1007/s10741-018-9724-x.